Skip Navigation


NDT Advance Access originally published online on September 26, 2007
Nephrology Dialysis Transplantation 2008 23(1):72-81; doi:10.1093/ndt/gfm581
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/1/72    most recent
gfm581v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Leung, J. C. K.
Right arrow Articles by Lai, K. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, J. C. K.
Right arrow Articles by Lai, K. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org



Synthesis of TNF-{alpha} by mesangial cells cultured with polymeric anionic IgA—role of MAPK and NF-{kappa}B

Joseph C. K. Leung, Sydney C. W. Tang, Loretta Y. Y. Chan, Wai Long Chan and Kar Neng Lai

Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong

Correspondence to: Prof. Kar Neng Lai, Department of Medicine, University of Hong Kong, Room 409, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong. Email: knlai{at}hkucc.hku.hk



  Abstract

Background. Deposition of polymeric IgA1 (pIgA) in kidney mesangium is the hallmark of IgA nephropathy (IgAN). Current consensus is that a fraction of IgA1 molecules in the circulation of IgAN patients exhibit aberrant structures or properties that may lead to their deposition. Our previous findings suggest that the anionic property of IgA1 may play a role in mesangial IgA1 deposition in patients with IgAN. In the present study, the functional consequences of the binding of anionic polymeric IgA1 to human mesangial cells (HMCs) were investigated.

Methods. Anionic polymeric IgA1 from IgAN patients and healthy subjects was isolated by sequential jacalin affinity chromatography, size exclusion chromatography using size exclusion and MonoQ ion exchange chromatography. HMCs were cultured with purified anionic polymeric IgA1 and the release of tumour necrosis factor-{alpha} (TNF-{alpha}) and interleukin-6 (IL-6) was examined by enzyme-linked immunosorbent assay. The signalling pathways involved in anionic pIgA-mediated HMC activation were examined by immunoblotting. Standard electrophoretic mobility shift assay (EMSA) was used to further examine whether the transcriptional factor NF-{kappa}B is associated in the signalling process. To define the mechanism of TNF-{alpha} and IL-6 production, HMCs were cultured with anionic pIgA in the presence or absence of p42/p44 mitogen-activated protein kinase (MAPK) inhibitor (PD98059), NF-{kappa}B inhibitor pyrrolidine dithiocarbamate (PDTC) or NF-{kappa}B blocking permeable peptides.

Results. Compared with less anionic pIgA or monomeric IgA1 (mIgA), anionic pIgA from patient with IgAN significantly increased cell proliferation (P < 0.05) when cultured with HMC. These anionic pIgA significantly increased the synthesis of TNF-{alpha} (P < 0.05) and IL-6 (P < 0.05) in a dose and time-dependent manner. Furthermore, the increased synthesis of IL-6 and TNF-{alpha} by anionic pIgA in HMC was significantly diminished (P < 0.01) in the presence of NF-{kappa}B inhibitor pyrrolidine dithiocarbamate and NF-{kappa}B blocking permeable peptides SN50 (P < 0.01). The increased synthesis of IL-6 by anionic pIgA in HMC was reduced by inhibitor to NF-{kappa}B or p42/p44 MAPK and was abolished by the simultaneous presence of inhibitors to p42/p44 MAPK and NF-{kappa}B. The up-regulation of TNF-{alpha} was partially suppressed by inhibitor to NF-{kappa}B but not PD98059.

Conclusion. Our results suggest that polymeric anionic IgA1 could activate HMC and increase the synthesis of TNF-{alpha} and IL-6. While both the p42/p44 MAPK and NF-{kappa}B pathways are essential in regulating the anionic pIgA-induced synthesis of IL-6, TNF-{alpha} synthesis mediated by anionic pIgA is partly dependent on NF-{kappa}B.

Keywords: anionic IgA; human mesangial cell; IgA nephropathy; polymeric IgA

Received for publication: 14. 3.07
Accepted in revised form: 31. 7.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. Xiao, J. C. K. Leung, L. Y. Y. Chan, H. Guo, and K. N. Lai
Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy
Nephrol. Dial. Transplant., July 1, 2009; 24(7): 2067 - 2077.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Jacquet, H. Francois, C. Frangie, Y. Yahiaoui, S. Ferlicot, C. Micelli, X. Mariette, and A. Durrbach
IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy
Nephrol. Dial. Transplant., June 25, 2009; (2009) gfp314v1.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
J. C. K. Leung, L. Y. Y. Chan, K. Y. Tam, S. C. W. Tang, M. F. Lam, A. S. Cheng, K. M. Chu, and K. N. Lai
Regulation of CCN2/CTGF and related cytokines in cultured peritoneal cells under conditions simulating peritoneal dialysis
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 458 - 469.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.